-
Value proposition
Building a legacy in female health
endogene.bio is building the biological data infrastructure for uterine health.
190 million women worldwide suffer from endometriosis, yet diagnosis still takes years and curative treatments remain unavailable. A fundamental challenge is the lack of high-quality human uterine biological data.
By combining menstrual blood, advanced molecular profiling, and computational modeling, endogene.bio generates high-resolution biological data at scale, unlocking a previously inaccessible layer of human biology.
Our work enables deeper understanding of disease mechanisms, patient stratification, biomarker discovery, and therapeutic development across uterine health.
We collaborate with pharmaceutical companies, hospitals, clinics, and research organizations to accelerate the next generation of diagnostics and therapeutics in women's health.
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
Bits & Pretzels
Events Services (Auto) |
Bits & Pretzels
Events Services (Auto) |
Other
30 Jun 2024 |
|
|
McKinsey & Company
Consulting, Business Consulting and Services (Auto) |
McKinsey & Company
Consulting, Business Consulting and Services (Auto) |
Other
30 Jun 2026 |
|
|
ASML
Semiconductors, Semiconductor Manufacturing (Auto) |
ASML
Semiconductors, Semiconductor Manufacturing (Auto) |
Other
30 Jun 2026 |
|
|
Hello Tomorrow
Trade show, Business Consulting and Services (Auto) |
Hello Tomorrow
Trade show, Business Consulting and Services (Auto) |
Other
30 Jun 2026 |
|
|
STATION F
Startup accelerator & VC, Technology, Information and Internet (Auto) |
STATION F
Startup accelerator & VC, Technology, Information and Internet (Auto) |
Other
30 Jun 2026 |
|
|
L'Oréal
Cosmetics, Consumer Services (Auto) |
L'Oréal
Cosmetics, Consumer Services (Auto) |
Other
30 Jun 2026 |
|
|
Genopole
Biotechnology, Biotechnology Research (Auto) |
Genopole
Biotechnology, Biotechnology Research (Auto) |
Other
30 Jun 2026 |
|
|